Related Experiment Video
Updated: Feb 21, 2026

Isolation, Transfection, and Long-Term Culture of Adult Mouse and Rat Cardiomyocytes
Published on: October 10, 2020
Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats
Lilian Grigorian-Shamagian1, Weixin Liu1, Soraya Fereydooni1
1Cedars-Sinai Heart Institute, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.
Insights
Cardiosphere-derived cells (CDCs) rejuvenate aged rats by improving heart function, reducing inflammation, and enhancing exercise capacity. This cell therapy reverses aging markers, promoting a younger physiological state.
Area of Science:
- Regenerative Medicine
- Cardiology
- Aging Research
Background:
- Diastolic dysfunction is a hallmark of aging hearts.
- Cardiosphere-derived cell (CDC) therapy shows promise for cardiac repair.
- The impact of CDCs on the aging process remains largely unevaluated.
Purpose of the Study:
- To investigate the effects of CDCs on cardiac structure, function, gene expression, and systemic parameters in aged rats.
- To determine if CDC therapy can reverse age-related cardiac decline.
Main Methods:
- Intracardiac injection of neonatal rat CDCs into aged rats, compared to a vehicle control.
- Assessment of cardiac function (echocardiography, hemodynamics), exercise capacity, and histology.
- Transcriptomic analysis to evaluate gene expression patterns and telomere length.
- In vitro studies using human heart cells exposed to CDCs or CDC-derived exosomes.
Main Results:
- CDC treatment restored youthful gene expression patterns in aged rat hearts.
- Telomeres were significantly longer in heart cells of CDC-treated animals.
- CDC therapy attenuated cardiac hypertrophy, reduced cardiomyocyte size and fibrosis, and improved diastolic function.
- Exercise capacity increased, and systemic inflammation markers improved in aged rats receiving CDCs.
- In vitro, CDC-derived exosomes increased telomerase activity and reduced senescence in aged heart cells.
Conclusions:
- Young CDCs effectively rejuvenate aged rats.
- CDC therapy improves cardiac function, exercise capacity, and systemic biomarkers of aging.
- This study highlights the potential of CDC therapy for combating age-related cardiac decline.
Aim:
The aim is to assess the effects of CDCs on heart structure, function, gene expression, and systemic parameters in aged rats. Diastolic dysfunction is characteristic of aged hearts. Cardiosphere-derived cell (CDC) therapy has exhibited several favourable effects on heart structure and function in humans and in preclinical models; however, the effects of CDCs on aging have not been evaluated.
Methods And Results:
We compared intra-cardiac injections of neonatal rat CDCs to vehicle (phosphate-buffered saline, PBS) in 21.8 ± 1.6 month-old rats (mean ± standard deviation; n = 23 total). Ten rats 4.1 ± 1.5 months of age comprised a young reference group. Blood, echocardiographic, haemodynamic and treadmill stress tests were performed at baseline in all animals, and 1 month after treatment in old animals. Histology and the transcriptome were assessed after terminal phenotyping. For in vitro studies, human heart progenitors from older donors, or cardiomyocytes from aged rats were exposed to human CDCs or exosomes secreted by CDCs (CDC-XO) from paediatric donors. Transcriptomic analysis revealed that CDCs, but not PBS, recapitulated a youthful pattern of gene expression in the hearts of old animals (85.5% of genes differentially expressed, P < 0.05). Telomeres in heart cells were longer in CDC-transplanted animals (P < 0.0001 vs. PBS). Cardiosphere-derived cells attenuated hypertrophy by echo (P < 0.01); histology confirmed decreases in cardiomyocyte area (P < 0.0001) and myocardial fibrosis (P < 0.05) vs. PBS. Cardiosphere-derived cell injection improved diastolic dysfunction [lower E/A (P < 0.01), E/E' (P = 0.05), end-diastolic pressure-volume relationship (P < 0.05) compared with baseline), and lowered serum brain natriuretic peptide (both P < 0.05 vs. PBS). In CDC-transplanted old rats, exercise capacity increased ∼20% (P < 0.05 vs. baseline), body weight decreased ∼30% less (P = 0.05 vs. PBS) and hair regrowth after shaving was more robust (P < 0.05 vs. PBS). Serum biomarkers of inflammation (IL-10, IL-1b, and IL-6) improved in the CDC group (P < 0.05 for each, all vs. PBS). Young CDCs secrete exosomes which increase telomerase activity, elongate telomere length, and reduce the number of senescent human heart cells in culture.
Conclusion:
Young CDCs rejuvenate old animals as gauged by cardiac gene expression, heart function, exercise capacity, and systemic biomarkers.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
08:24Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
The Effect of Aging on Tissues